China Health Resource, Inc. (fka CHRI)

[downthehatch]

Ending talks with HBRM confirms several things:
1- CHRI management will not overpay for a U.S. presence
2- Management is still focused on generating real revenue and profits, not on hype and short term stock performance
3- CHRI is still focused on its core business, TCM's sold basically into the Chinese market, with potential global sales as well.

I think we should close over .03 today, and should end the month much higher. With earnings out next month. We could be double the current price by then, easily. IMO, of course.